Fatty liver disease: Diabetes risk increased due to insulin resistance - how to treat?
FATTY liver disease: Diabetes raises a person's risk of non-alcoholic fatty liver disease, a condition in which excess fat builds up in the liver even if you drink little or no alcohol. This condition occurs in at least half of those with type 2 diabetes. (Source: Daily Express - Health)
Source: Daily Express - Health - April 14, 2021 Category: Consumer Health News Source Type: news

Increased risk of liver cancer in patients with non-alcoholic fatty liver
(Karolinska Institutet) Non-alcoholic fatty liver, NAFLD, is associated with several health risks. According to a new registry study led by researchers at Karolinska Institutet in Sweden, NAFLD is linked to a 17-fold increased risk of liver cancer. The findings, published in Hepatology, underscore the need for improved follow-up of NAFLD patients with the goal of reducing the risk of cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 14, 2021 Category: Cancer & Oncology Source Type: news

Non-alcoholic fatty liver disease symptoms: Three symptoms that signal 'permanent' damage
NON-ALCOHOLIC fatty liver disease often goes undetected until it progresses to cirrhosis. What is cirrhosis and what are the symptoms to expect? (Source: Daily Express - Health)
Source: Daily Express - Health - April 13, 2021 Category: Consumer Health News Source Type: news

Closer to human -- Mouse model more accurately reproduces fatty liver disease
(Baylor College of Medicine) Researchers have developed a novel mouse model that reproduces many key features of human non-alcoholic fatty liver disease (NAFLD), a little-understood condition that significantly increases the risk of inflammation, fibrosis and liver cancer and ultimately requires liver transplant. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 13, 2021 Category: Cancer & Oncology Source Type: news

Bariatric Surgery Cuts Cancer Risk With Obesity + Liver Disease
FRIDAY, April 9, 2021 -- Bariatric surgery is associated with significant reductions in the risks for any cancer and obesity-related cancer in nonalcoholic fatty liver disease (NAFLD) patients with severe obesity, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2021 Category: Pharmaceuticals Source Type: news

Fatty liver disease symptoms: Three symptoms that are so subtle you might miss them
FATTY liver disease is an umbrella term for conditions characterised by a build-up of fat in the liver. Non-alcoholic fatty liver disease is largely symptomless until the condition progresses - when this happens, a number of subtle symptoms may surface. (Source: Daily Express - Health)
Source: Daily Express - Health - April 8, 2021 Category: Consumer Health News Source Type: news

Coffee Could Be the Secret Weapon Against NAFLD Coffee Could Be the Secret Weapon Against NAFLD
"I do recommend at least two to three cups of coffee per day for my patients with NAFLD [nonalcoholic fatty liver disease]," said Manal F. Abdelmalek, MD, MPH.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 7, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

TGen-ASU review suggests added sugars are contributing to liver disease among children
(The Translational Genomics Research Institute) A review of more than 20 studies by researchers at Arizona State University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggests that nonalcoholic fatty-liver disease (NAFLD) is a growing dietary problem for children across the globe. NAFLD affects more than 1-in-10 children in the U.S. and now is the nation's most common chronic liver disease within this population. The analyses were published recently in the journal, Pediatric Obesity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2021 Category: International Medicine & Public Health Source Type: news

Fatty liver disease: The four early warning signs you could easily miss - 'dull pain'
FATTY liver disease is an umbrella term for fatty build-ups in the liver. Non-alcoholic fatty liver disease is one the main types of fatty liver disease - here are four hard to spot early warning signs. (Source: Daily Express - Health)
Source: Daily Express - Health - March 23, 2021 Category: Consumer Health News Source Type: news

Fatty liver disease: Four hard to spot early symptoms including a dull pain in the stomach
FATTY liver disease is an umbrella term for fatty build-ups in the liver. Non-alcoholic fatty liver disease is one the main types of fatty liver disease - here are four hard to spot early warning signs. (Source: Daily Express - Health)
Source: Daily Express - Health - March 23, 2021 Category: Consumer Health News Source Type: news

New study implicates disease-driving B cells in fatty liver disease development
(University of Minnesota Medical School) New research from the University of Minnesota Medical School suggests that disease-driving B cells, a white blood cell, play a role in the development of non-alcoholic fatty liver disease (NAFLD) - the most common chronic liver condition in the U.S. Their findings could lead to targeted therapies for NAFLD, which currently affects a quarter of the nation and has no FDA-approved treatments. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 22, 2021 Category: Biology Source Type: news

Sex Steroid Hormone Concentrations and NAFLD in Men Sex Steroid Hormone Concentrations and NAFLD in Men
Some studies have indicated that men are at higher risk of NAFLD than women. Might testosterone levels impact the development of NAFLD?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Consumption of Edible Seaweeds and Newly Diagnosed NAFLD Consumption of Edible Seaweeds and Newly Diagnosed NAFLD
Might seaweed consumption, with its rich anti-oxidant and anti-inflammatory properties, be protective against NAFLD?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 4, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease
(New York University) An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and potential therapeutic target for non-alcoholic fatty liver disease, according to a study published in the Journal of Hepatology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 4, 2021 Category: Biology Source Type: news

Adequate glutathione intake found to boost liver health
(Natural News) A recent study has found that supplementation with glutathione could help reverse liver damage associated with nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by the accumulation of excess fat in the liver, which, if left untreated, can progress to a more aggressive form of liver disease called nonalcoholic steatohepatitis (NASH). NASH is accompanied by inflammation... (Source: NaturalNews.com)
Source: NaturalNews.com - February 24, 2021 Category: Consumer Health News Source Type: news

Operational guidelines launched for integration of Non-Alcoholic Fatty Liver Disease with NPCDCS
"Over the last two decades global burden of NASH has more than doubled. Globally, NASH caused 40 lakh prevalent cases of compensated cirrhosis in 1990, which increased to 94 lakh cases in 2017. NAFLD is emerging as an important cause of liver disease in India," Vardhan was quoted as saying in a Health Ministry statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Steatosis Severity in NAFLD and Coronary Plaque Pattern Steatosis Severity in NAFLD and Coronary Plaque Pattern
Is steatosis severity in NAFLD independently associated with coronary artery atherosclerosis burden?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

' CAP' Quantification of Liver Fat Not Reliable for Routine Use'CAP' Quantification of Liver Fat Not Reliable for Routine Use
Ultrasound-based controlled attenuation parameter (CAP) should be used with caution because while results are reliable in patients with viral hepatitis, that's not the case for NAFLD, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 9, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

AGA Practice Update: Bariatric Surgery in Patients With Cirrhosis AGA Practice Update: Bariatric Surgery in Patients With Cirrhosis
According to one study cited in the update, approximately 30% of patients with cirrhosis have comorbid obesity, and this figure may increase even further as the epidemic of NAFLD progresses.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 8, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Intestinal Permeability in Human NAFLD Intestinal Permeability in Human NAFLD
What might be the role of alterations in intestinal permeability and NAFLD presence and/or severity?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 28, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Fatty liver disease symptoms: Spider veins on your body are a warning sign
FATTY liver disease, also known as non-alcoholic fatty liver disease , is the term for a range of conditions caused by a build-up of fat in the liver. Signs usually show up in the latter stages, such as spider veins. (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2021 Category: Consumer Health News Source Type: news

Fatty liver disease symptoms: Red palms could be sign of ‘aggressive’ form of condition
FATTY liver disease, also known as nonalcoholic fatty liver disease, can lead to serious health complications if left untreated. Red palms can be a sign of an "aggressive" form of the condition - nonalcoholic steatohepatitis. (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2021 Category: Consumer Health News Source Type: news

CT spots patients with high-risk liver disease
The Fibrosis-4 (FIB-4) index and multiple CT findings can identify patients...Read more on AuntMinnie.comRelated Reading: Can AI screen for nonalcoholic fatty liver disease? Ultrasound options abound for diagnosing liver disease Quantitative imaging biomarkers show promise for NASH MRI protocol could replace biopsy for pediatric liver disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 23, 2021 Category: Radiology Source Type: news

Fatty liver disease symptoms: The visual warning sign on your legs, ankles and feet
FATTY liver disease is a common condition caused by the storage of extra fat in the liver. Non-alcoholic fatty liver disease is one of the main types of fatty liver disease. Swelling in the legs, ankles, feet or tummy is associated with the advanced stage of NAFLD. (Source: Daily Express - Health)
Source: Daily Express - Health - January 22, 2021 Category: Consumer Health News Source Type: news

CT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)
(American Roentgen Ray Society) According to ARRS' American Journal of Roentgenology, Fibrosis-4 and multiple CT findings can identify patients with high-risk nonalcoholic fatty liver disease--advanced fibrosis or cirrhosis, that is--though the presence of nonalcoholic steatohepatitis remains elusive on CT. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2021 Category: Cancer & Oncology Source Type: news

Green med diet cuts non-alcoholic fatty liver disease by half - Ben-Gurion U. study
(American Associates, Ben-Gurion University of the Negev) Overall, the green MED diet produced dramatic reductions in fatty liver. NAFLD prevalence dropped from 62% at baseline to 31.5% in the green Mediterranean group, down to 47.9% in the Mediterranean group and 54.8% in the healthy dietary regimen group. Addressing this common liver disease by targeted lifestyle intervention might promote a more effective nutritional strategy. This Ben-Gurion University of the Negev clinical trial demonstrates an effective nutritional tool for NAFLD beyond weight loss (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 18, 2021 Category: Biology Source Type: news

High-protein Diet More Effectively Reduces Hepatic Fat High-protein Diet More Effectively Reduces Hepatic Fat
This study investigated whether low- or high-protein diets are more effective in reducing liver fat and reversing NAFLD. What might be the possible mechanisms involved?Liver International (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 14, 2021 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Fatty Liver Disease-A Multifaceted Disease With Multiple Names? Fatty Liver Disease-A Multifaceted Disease With Multiple Names?
In this commentary, the authors suggest that a more precise terminology for NAFLD is needed, with a more granular view on subcategories of NASH to guide preventive and therapeutic measures.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 7, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

How Diet and Exercise Can Help Manage NAFLD, According to the AGA How Diet and Exercise Can Help Manage NAFLD, According to the AGA
"[W]eight loss is associated with a reduction in liver fat, which provides a potential for reversal of disease progression," wrote Zobair M. Younossi, MD, MPH.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 6, 2021 Category: Internal Medicine Tags: Gastroenterology News Source Type: news

Zydus Cadila receives DCGI nod for NAFLD drug Saroglitazar Mg in India
Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patients who do not consume alcohol or take it in insignificant amounts, but have risk factors such as overweight or obesity, diabetes mellitus (high blood sugar), hypertension (high blood pressure) or dyslipidemia (abnormal blood lipids). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 30, 2020 Category: Pharmaceuticals Source Type: news

Mayo Clinic Q & amp;A podcast: Two ends of the nutrition spectrum in children
Pediatric growth charts track growth in infants, children and adolescents. While children can go through brief periods where they gain or lose a little weight, if children don't gain weight or grow well, they may be diagnosed with failure to thrive. On the other end of the nutrition spectrum are children with non-alcoholic fatty liver [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 4, 2020 Category: Databases & Libraries Source Type: news

NAFLD Prevalence Rising Among Children but Many Undiagnosed NAFLD Prevalence Rising Among Children but Many Undiagnosed
The incidence of nonalcoholic fatty liver disease (NAFLD) is rising among children, but not all youth with obesity are getting recommended screening, a study in California suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 20, 2020 Category: Consumer Health News Tags: Pediatrics News Source Type: news

2009 to 2018 Saw Increase in Incidence of NAFLD in Children
THURSDAY, Nov. 19, 2020 -- From 2009 to 2018, there was an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) among children, although many still remain undiagnosed, according to a study published online Nov. 19 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2020 Category: Pharmaceuticals Source Type: news

Lipid Profiles Distinguish Obese and Nonobese NAFLD Patients Lipid Profiles Distinguish Obese and Nonobese NAFLD Patients
Both obese and nonobese individuals can develop nonalcoholic fatty liver disease, and lipid profiles were effective predictors in both groups, based on data from a cross-sectional study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Mayo Clinic Q & amp;A podcast: Cardiometabolic diseases increase COVID-19 risk
An estimated 47 million Americans are living with cardiometabolic diseases, according to the American College of Cardiology. Cardiometabolic diseases are interrelated conditions that include cardiovascular diseases, such as heart disease, stroke, and hypertension, as well as metabolic diseases, such as Type 2 diabetes, obesity and nonalcoholic fatty liver disease. Patients with cardiometabolic diseases have a [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 13, 2020 Category: Databases & Libraries Source Type: news

Eating less suppresses liver cancer due to fatty liver
(Shinshu University) Liver cancer from too much fat accumulation in the liver has been increasing in many countries including Japan. In order to change this unfortunate state of affairs, it is important to improve the prognosis of non-alcoholic fatty liver disease. Fatty liver is often improved through eating less, getting more exercise, and reducing body weight. The research group posed the question, " Can eating less also suppress liver cancer caused by fatty liver? " (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 29, 2020 Category: Cancer & Oncology Source Type: news

Start-up awarded grant to develop contrast agent for early detection of liver disease
(Georgia State University) Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents' Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 15, 2020 Category: International Medicine & Public Health Source Type: news

Predictors of Mortality and Disease Progression in NAFLD Predictors of Mortality and Disease Progression in NAFLD
This study aimed to elucidate the factors associated with mortality and disease progression in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a real-world cohort.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 14, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NAFLD Closely Tied to Diabetes Risk NAFLD Closely Tied to Diabetes Risk
Patients with non-alcoholic fatty-liver disease (NAFLD) have a higher risk of diabetes, and the more severe the disease the greater the risk, according to new research.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 8, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Newer Antidiabetic Drugs Linked to Improved Liver Enzymes, Steatosis Newer Antidiabetic Drugs Linked to Improved Liver Enzymes, Steatosis
Early evidence suggests that newer diabetes drugs such as pioglitazone may improve liver enzymes and hepatic steatosis and could possibly be useful in treating non-alcoholic fatty liver disease (NAFLD), researchers say.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - October 6, 2020 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World Comparison of MAFLD and NAFLD Diagnostic Criteria in Real World
How does the criteria for the newly-coined concept"metabolic associated fatty liver disease" differ from those for non-alcoholic fatty liver disease, and what are the real-world implications?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

AI plus CT improves liver steatosis assessment
Artificial intelligence (AI) used with contrast-enhanced abdominal CT makes...Read more on AuntMinnie.comRelated Reading: Can AI screen for nonalcoholic fatty liver disease? Ultrasound useful for evaluating liver steatosis MRI offers view of liver fat loss in obese patients Steatosis complicates MR elastography for liver fibrosis AIUM: Can deep learning classify liver fibrosis on US? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 22, 2020 Category: Radiology Source Type: news

How high fructose intake may trigger fatty liver disease
A study suggested that consuming high amounts of fructose may promote non-alcoholic fatty liver disease by damaging the intestinal barrier. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - September 14, 2020 Category: Consumer Health News Source Type: news

Researchers find molecular link between liver disease, insulin resistance
Yale researchers have zeroed in on a molecular link between nonalcoholic fatty liver disease and liver insulin resistance in type 2 diabetes. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 2, 2020 Category: Universities & Medical Training Source Type: news

Menopause may increase risk for non-alcoholic fatty liver disease
Postmenopausal women may be more likely to develop non-alcoholic fatty liver disease due to a reduction in sex hormones, suggests a study published in Endocrinology.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 26, 2020 Category: Endocrinology Source Type: news

New insights into mechanism of therapy to reduce liver fat and prevent fibrosis
(Massachusetts General Hospital) A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 26, 2020 Category: International Medicine & Public Health Source Type: news

TGen review suggests postmenopausal women at risk for nonalcoholic fatty liver disease
(The Translational Genomics Research Institute) NAFLD is the most common cause of liver damage, and can lead to liver cirrhosis and death. It affects nearly 1 in 4 people across the globe. It often is associated with obesity, abnormally high amounts of lipids in the blood, and type 2 diabetes. In the US, the number of NAFLD cases is expected to grow to more than 100 million within the next decade, annually costing an estimated at $292 billion. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 14, 2020 Category: International Medicine & Public Health Source Type: news

NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation NAFLD May Predict Arrhythmia Recurrence Post-AF Ablation
The presence of nonalcoholic fatty liver disease adds a further modifiable target for preablation medical optimization, researchers say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 14, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Fatty liver disease despite a normal weight
(University of Tsukuba) Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index. They found that non-obese NAFLD patients had lower muscle mass and strength (pre-sarcopenia) compared to obese NAFLD patients. Further, fat accumulation in muscles was more common among women. These findings help us understand the clinical presentation of NAFLD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2020 Category: International Medicine & Public Health Source Type: news

NAFLD: It's More Than Just the Fat NAFLD: It's More Than Just the Fat
As a'big club'that everyone could belong to, it's past time to understand NAFLD better.The Curbsiders (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news